From May 8 to 10, 2026, the 23rd SIS World Congress on Breast Cancer and Breast Healthcare, a premier international academic event in the field of breast health, was held in Tianjin.

The conference was jointly organized by the Senologic International Society (SIS) and China Anti-Cancer Association (CACA), and co-hosted by Tianjin Medical University Cancer Institute & Hospital (TMUCIH), the Tianjin Breast Cancer Prevention and Treatment Center, and the National Clinical Research Center for Cancer, drawing global attention to Tianjin.

The conference brought together over 1,000 leading experts and scholars in the field of breast health from 21 countries and regions, including Academician Fan Daiming, President of CACA, Academician Hao Xishan, Honorary President of CACA, Prof. Carole Mathelin, President of SIS and President of French Academy of Surgery, and Prof. Vahit Ozmen, former President of SIS and Professor in the Department of Surgery at Istanbul University School of Medicine. They engaged in in-depth and professional discussions on cutting-edge topics such as breast disease prevention and screening, pathological and imaging diagnosis, precision treatment in surgery and medicine, basic research translation, nursing rehabilitation, and whole-cycle management. The conference established a high-end academic exchange platform that transcended national borders and disciplines, collectively shaping the future development of global breast health.

Academician Fan, President of CACA, President of Asian Oncology Society (AOS), and President of World Association for Integrative Oncology (WAIO), pointed out that breast cancer, as a global health challenge affecting people worldwide, requires international collaboration that knows no borders. The significance of holding this conference in China is particularly profound. Over the past five years, China has made significant strides in promoting early screening, early diagnosis, and early treatment systems for breast cancer at the grassroots level. The practical achievements in breast cancer prevention and treatment for Chinese women have been incorporated into CACA Guidelines and promoted globally. SIS views this conference as a key opportunity to deepen international academic exchange and share cutting-edge clinical experience, highlighting China's growing international influence and voice in the field of breast health.

Academician Hao, Board Director of SIS, Director of the National Clinical Research Center for Cancer, and Director of TMUCIH, noted that the successful hosting of this conference in Tianjin would not have been possible without the trust and support of SIS and all board members. It also represents a significant initiative for global colleagues to strengthen East-West cooperation. The conference not only provides an international high-end platform to comprehensively showcase the comprehensive capabilities of China and Tianjin in the field of breast cancer diagnosis and treatment but also plays an active and crucial role in advancing global breast cancer prevention and treatment efforts and improving the level of global breast health.

Prof. Carole Mathelin, President of SIS and President of French Academy of Surgery, stated that breast cancer and other breast diseases have become major public health challenges seriously threatening the health and quality of life of women worldwide, posing urgent issues for all countries. The successful convening of this conference in Tianjin marks the international community's high recognition of China's capabilities and academic standards in breast disease prevention and treatment. SIS looks forward to using this opportunity to engage in deeper and broader exchanges and cooperation with China.

Prof Hao Jihui, Secretary of the Party Committee and President of TMUCIH, and Executive Chair of this congress, stated that as the host institution, TMUCIH has demonstrated the mature paradigm of the "Tianjin Solution." The hospital is home to Asia's largest breast cancer prevention and treatment research center and holds a leading position nationwide in breast cancer prevention, diagnosis, treatment, and research. The hospital has established China's first independent breast oncology specialty hospital, handling over 500,000 outpatient visits annually and performing more than 10,000 surgeries each year. It has achieved an integrated management model of "single disease, multidisciplinary, and whole-cycle care," allowing patients to complete imaging, pathology, surgery, internal medicine, radiotherapy, psychological support, and other services on a single platform from initial diagnosis to rehabilitation, effectively breaking down disciplinary barriers.

The opening ceremony was presided over by Prof. Wang Ying, Vice President of CACA, and also a Board member of SIS.

Keynote reports were delivered by experts including former President of SIS, Prof. Vahit Ozmen; Academician Song Erwei of Sun Yat-sen Memorial Hospital, Sun Yat-sen University; President of SIS, Prof. Carole Mathelin; Prof. Wu Jiong, Executive Director of the Integrated Breast Cancer Committee of CACA, Party Secretary and Director of the Breast Center at Fudan University Shanghai Cancer Center; Vice President of SIS and founder of the Breast Center at Niels-Stensen Hospital in Germany, Prof. Alexander Mundinger; Prof. Jiang Zefei, Deputy Director of the Oncology Department of the PLA General Hospital; Academician Yu Jinming of Shandong Cancer Hospital; former President of SIS and member of the Brazil National Academy of Medicine, Prof. Mauricio Magalhaes Costa; former Chair of the Breast Cancer Committee of CACA and Prof. Shao Zhimin of Fudan University Shanghai Cancer Center; Prof. Schlomo Schneebaum of Tel Aviv University; Prof. Zhang Jin, Chair of the Breast Cancer Committee of CACA and representative of Breast Cancer Prevention and Treatment Research Center at TMUCIH; Prof. Bolívar Arboleda-Osorio of University of Puerto Rico Hospital; Prof. Tadeusz Pieńkowski of the Postgraduate Medical Education Center in Warsaw, Poland; and Prof. Hu Xichun of Fudan University Shanghai Cancer Center.

The conference featured one main forum and ten sub-forums, with content centered on the whole-cycle, precision, and standardized diagnosis and treatment of breast cancer. In-depth academic discussions were conducted on core aspects such as prevention and screening, surgical treatment, comprehensive therapy, and basic and translational research, providing a rich and diverse platform for exchange among experts and scholars.

In the prevention and screening sessions, the conference systematically reviewed and summarized the latest strategies for identifying high-risk populations, early screening, and risk control for breast cancer, providing a scientific and solid foundation for precision prevention. In the field of surgical treatment, experts explored new concepts and technologies guided by minimally invasive, breast-conserving, and de-escalation approaches, advancing breast cancer surgery toward greater precision. The comprehensive treatment sessions showcased breakthrough progress in targeted therapy, radiotherapy, immunotherapy, and innovative vaccines, offering diverse options to improve treatment outcomes for breast cancer. Additionally, the conference featured lively discussions on key issues such as pathogenic mechanisms, clinical translation, and the balanced development of global medical resources, reaching important academic consensus.

This conference provided a high-end academic exchange platform for experts and scholars in the global breast health field, effectively promoting the exchange and integration of Eastern and Western medical concepts and fully demonstrating China's outstanding achievements in breast cancer prevention and treatment. Looking ahead, colleagues in the global breast health field will continue to uphold the principles of cooperation and win-win outcomes, strengthen collaboration, share research findings, and work together to advance global breast health to new heights. Media outlets covering the conference included Xinhua News Agency, China Global Television Network, People's Daily Health Client, China Medical Tribune, Physician's Daily, Tianjin Daily, and Jin Yun.